Change of plasma leukotriene C4 during myocardial ischemia in humans

Clinical Cardiology

Volumn 19, Issue 3, 1996, Pages 198-204

  Takase, Bonpei ^a   Kurita, Akira ^a   Maruyama, Toshiharu ^a   Uehata, Akimi ^a   Nishioka, Toshihiko ^a   Mizuno, Kyoichi ^a   Nakamura, Haruo ^a   Katsura, Kenichiro ^b   Kanda, Yoshikazu ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

acute myocardial infarction; chronic stable angina; leukotriene C4; myocardial ischemia

Indexed keywords

LEUKOTRIENE C4;

ADULT; AGED; ANGINA PECTORIS; ARRHYTHMOGENESIS; ARTICLE; BICYCLE ERGOMETRY; BLOOD VESSEL PERMEABILITY; CORONARY SINUS; DRUG BLOOD LEVEL; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LEUKOCYTE FUNCTION AND CHARACTERISTICS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RADIOIMMUNOASSAY;

EID: 0029790328     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190312     Document Type: Article

References (31)

1. Carry M, Korley V, Willerson JT, Weigelt L, Ford-Hutchinson AW, Tagari P: Increased urinary leukotrienes excretion in patients with cardiac ischemia. Circulation 85, 230-236 (1992)
2. Servi S, Ricevuti G, Mazzone A, Ghio S, Zito A, Raffaghello S, Specchia G: Granulocyte function in coronary artery disease. Am J Cardiol 68, 64B-68B (1991)
3. Friedman GD, Klatsky AL, Siegelaub AB: The leukocyte count as a predictor of myocardial infarction. N Engl J Med 290, 1275-1278 (1974)
4. Lowe GDO, Machado SG, Krol W: White blood cell count and hematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 54, 700-703 (1985)
5. Fauler J, Frolich C: Cardiovascular effects of leukotrienes. Cardiovasc Drugs Therapy 3, 499-505 (1989)
6. Barst S, Mullarie K: The release of a leukotriene D4-like substance following myocardial infarction in rabbits. Eur J Pharmacol 114, 383-387 (1985)
7. Chiu PS, Vemulapalli S, Bryant RW: Augmentation of leukotriene C4 and D4 release due to severe stenosis in the canine coronary artery stimulated by the calcium ionophore A23187. Biochem Pharmacol 35, 3593-3599 (1986)
8. Kuzuya T, Hoshida S, Nishida M, Kim Y, Kodama T, Tada M: Increased production of arachidonate metabolism in an occlusion-perfusion model of canine myocardial infarction. Clin Res 21, 551-558 (1987)
9. Rosolowsky M, Falck JR, Willerson JT, Cambell WB: Synthesis of lipoxygenase and lipoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res 66, 608-621 (1990)
10. Mullarie K, Hatala MA, Kraemer R, Sessa W, Westlin W: Myocardial salvage induced by REV-5901 an inhibitor and antagonist of the leukotrienes. J Cardiovasc Pharmacol 10, 398-405 (1987)
11. Itoh T, Toki Y, Hieda N, Okamura K, Hashimoto H, Ogawa K, Satake T: Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart. Jpn Circ J 53, 1115-1121 (1989)
12. ISFC/WHO: Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 59, 607-609 (1979)
13. Mizuno K, Arakawa K, Shibuya T, Horiuti K, Matsui H, Takase B, Isojima K, Kurita A: Improved regional diastolic performance in patients with coronary artery disease post percutaneous transluminal coronary angioplasty. Am Heart J 115, 302-306 (1988)
14. Forrester JS, Diamond GA, Swan HJC: Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cordial 39, 139-145 (1977)
15. Isono T, Koshihara Y, Murota S, Fukuda Y, Furukawa S: Measurement of immunoreactive-leukotriene C4 in blood of asthmatic children. Biochem Biophys Res Commun 130, 486-492 (1985)
16. Kastura K, Minamizawa H, Katayama Y, Shimizu J, Goto Y, Urushiyama K, Terashi A, Kanda Y, Yoshino Y: Plasma levels of leukotriene C4, B4 and slow reacting substance of anaphylaxis in chronological phases of cerebrovascular disease. Prostaglandins 36, 655-665 (1988)
17. Ricevuti R, DeServi S, Mazzone A, Angoli L, Ghio S, Specchia G: Increased neutrophil aggregability in coronary artery disease. Eur Heart J 11, 814-818 (1990)
18. Mehta J, Dinerman J, Mehta P, Saldeen TP, Lawson D, Donnely WH, Wallin R: Neutrophil function in ischemic heart disease. Circulation 79, 549-556 (1989)
19. Mehta J, Feldman RL, Mehta JL, MacDonald RG, Letts G, Dorval MF: Effect of human coronary occlusion on thromboxane A2 and leukotriene C4 release. J Am Coll Cardiol 7, 107A (1986)
20. Wagai F, Uetsuka N, Kinoshita M, Watanabe H, Kitamura S: Inactivation of vasoactive substances in the canine lung. Jpn J Thoracic Dis 23, 1337-1342 (1985)
21. Hartung HP, Kladetzky RG, Melnik B, Hennerici M: Stimulation of the scavenger receptor on monocytes-macrophages evokes release of arachidonic acid metabolites and reduced oxygen species. Lab Invest 55, 209-216, (1986)
22. Tomoike H, Egashira K, Yamada A, Hayashi Y, Nakamura M: Leukotriene C4- and D4-induced diffuse peripheral constriction of swine coronary artery accompanied by ST elevation on the electrocardiogram: Angiographic analysis. Circulation 76, 480-487 (1987)
23. Simmet TH, Lange K, Degitz K, Dembinska-Kiec A, Hoppe U, Peskar BM: Release and effects of sulfidopeptide-leukotrienes in heart and vascular tissues. Adv Prostagl Thromb Leukotriene Res 16, 261-267 (1986)
24. Steven JF: Cooperative synthesis of leukotrienes by leukocytes and vascular cells. Ann N Y Acad Sci 524, 122-132 (1988)
25. Ezura D, Boyd LM, Goldstein RF, Feuerstein G: Effects of calcium entry blockers on coronary constriction and myocardial constriction and myocardial ischemia due to eukotriene D4. J Pharmacol Exp Ther 233, 229-234 (1984)
26. Mallory GK, White RD, Sacedo-Salagau J: The speed of healing of myocardial infarction. A study of the pathologic anatomy in seventy-two cases. Am Heart J 19, 647-671 (1939)
27. Ueno A, Tanaka K, Katori M: Possible involvement of thromboxane in bronchoconstrictive and hypertensive effects of LTC4 and LTD4 in guinea pigs. Prostaglandins 23, 865-880 (1982)
28. Hamel R, Masson P, Ford-Hutchinson AW, Jones TR, Brunet G, Prechuta H: Differing mechanisms for leukotriene D4-induced bronchoconstriction in guinea pigs following intravenous and aerosol administration. Prostaglandins 24, 419-432 (1982)
29. Friedrich T, Lichey J, Niigam S, Prieznitz M, Wegscheider K: Follow up of prostaglandin plasma levels after acute myocardial infarction. Am Heart J 109, 218-222 (1985)
30. Tada M, Hoshoda S, Kuzuya T, Inoue M, Minamino T, Abe H: Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction. Int J Cardiol 8, 301-312 (1985)
31. Takatsu Y, Yui Y, Hattori R: Platelet aggregation and thromboxane B2 release in patients with acute myocardial infarction: Their relation to coronary patency. Jpn Circ J 52, 314-320 (1988)